v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Ordinary Shares
Accumulated other comprehensive loss
Accumulated deficit
Balance at beginning of the period (in shares) at Dec. 31, 2024   691,400,000    
Balance at beginning of the period at Dec. 31, 2024 $ 5,139.0 $ 12,978.8 $ (526.3) $ (7,313.5)
Increase (Decrease) in Shareholders' Equity        
Vesting of restricted stock units (in shares)   5,100,000    
Share-based award activity (in shares)   (1,700,000)    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 6.3 $ 6.3    
Stock repurchased and retired (in shares)   (11,700,000)    
Stock Repurchased and Retired During Period, Value (50.0) $ (50.0)    
Net income (loss) (103.9)     (103.9)
Other comprehensive income (loss) 35.7   35.7  
Balance at end of the period (in shares) at Mar. 31, 2025   683,100,000    
Balance at end of the period at Mar. 31, 2025 5,027.1 $ 12,935.1 (490.6) (7,417.4)
Balance at beginning of the period (in shares) at Dec. 31, 2025   640,700,000    
Balance at beginning of the period at Dec. 31, 2025 4,842.9 $ 12,810.6 (453.1) (7,514.6)
Increase (Decrease) in Shareholders' Equity        
Vesting of restricted stock units (in shares)   8,100,000    
Share-based award activity (in shares)   (2,600,000)    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition $ 8.8 $ 8.8    
Stock repurchased and retired (in shares) (7,000,000.0) (7,000,000.0)    
Stock Repurchased and Retired During Period, Value $ (18.1) $ (18.1)    
Net income (loss) (40.2)     (40.2)
Other comprehensive income (loss) (4.6)   (4.6)  
Balance at end of the period (in shares) at Mar. 31, 2026   639,200,000    
Balance at end of the period at Mar. 31, 2026 $ 4,788.8 $ 12,801.3 $ (457.7) $ (7,554.8)